Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.

IFN-γ) to memory subsets yielded increased expression for high cytokine-producing subsets after gemcitabine although this did not reach statistical significance (Fig.

also in 111,027 other papers